2018-04-26Intravenous Enzyme Replacement Therapy for Fabry Disease (Health Service Executive (HSE))
The HSE wishes to establish a new national multi-supplier contract for the provision of Intravenous Enzyme Replacement Therapy (ERT) for Fabry Disease. The contract will support the delivery of ERT treatment to patients in either a hospital setting or in their own home. The scope of the contract includes the supply of medication to hospitals and to patients in a home setting and also the provision of infusion accessories and a nursing service for the administration of ERT to patients at home.
The HSE is โฆ
View the procurement ยป
2012-05-22Provision of Support Services for an Outpatient Parental Antimicrobial Therapy Service for the HSE (Health Service Executive (HSE))
The HSE invites Expressions of Interest from suitably qualified tenderers who wish to participate in a competition for the provision of Support Services for an Outpatient AntiMicrobial Therapy Service for the HSE.
The required Services are Annex IIB services, and accordingly, only Articles 23 & 35 (4) of the onsolidated Public Procurement Directive 2004/18/EC for Award of public service contracts, as amended, apply to the award of any contract arising from this process.
Note: To register your interest in โฆ
View the procurement ยป
2011-08-09Provision of Support Services for an Outpatient Parental Antimicrobial Therapy Service for the HSE (Health Service Executive (HSE))
The HSE invites Expressions of Interest from suitably qualified companies who wish to participate in a competition for the provision of Support Services for an Outpatient Parental Antimicrobial Therapy Service for the HSE.
The required services are Annex IIB services, and accordingly, only Articles 23 & 35 (4) of the Consolidated Public Procurement Directive 2004/18/EC for the Award of public service contracts, as amended, apply to the award of any contract arising from this process.
NOTE: To register โฆ
View the procurement ยป